Showing results (221-230 of 239) with videos related to
Sort By:
Pageof 24
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma GroupP Pautier, A Floquet, L Gladieff, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2014
Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG)F Duffaud, P Meeus, J B Bachet, et al.Anti-Cancer Drugs|March 23, 2001
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group StudyF Duffaud, M E van der Burg, M Namer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆P G Casali, A Le Cesne, A P Velasco, et al.ESMO Open|February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)C Moreau-Bachelard, L Campion, M Toulmonde, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'P Schöffski, A Wozniak, S Stacchiotti, et al.Diabetes & Metabolism|June 17, 2008
Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patientsA Bégu-Le Corroller, R Valéro, V Moutardier, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 15, 2010
[First trimester screening for Down syndrome: five years prospective experience]A-S Weingertner, N-T Trieu, M Kohler, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 29, 2012
[Epidemiology of orofacial clefts (1995-2006) in France (Congenital Malformations of Alsace Registry)]B Doray, D Badila-Timbolschi, E Schaefer, et al.Pageof 24